← All organizations
Highest phase reached
Phase 4
First clinical trial
Oct 1, 2003Last known activity
Nov 30, 2024
Timeline
1970s
- Jan 1, 1977
The EMMES Corporation— Founded
2020s
- May 12, 2021
Orphan Reach— Acquired
Drugs by trial phase (116 distinct, 106 trials)
Phase 4 (6 own, 0 via acquisition)
Phase 3 (23 own, 1 via acquisition)
- metronidazole
- procaine benzylpenicillin
- fluorouracil
- leuprolide
- imiquimod
- terbutaline
- lorazepam
- topiramate
- human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant
- piperacillin
- propranolol
- bevacizumab
- glucagon
- human papillomavirus 9-valent vaccine, recombinant
- recombinant human papillomavirus virus type 6/11 bivalent vaccine
- +9 more
Phase 2 (56 own, 1 via acquisition)
Phase 1 (28 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
- Acquired Immunodeficiency Syndrome
- Adenoviridae Infections
- Alphavirus Infections
- Anemia, Aplastic
- Anus Neoplasms
- Arthritis
- Arthritis, Juvenile
- Atrophy
- Autism Spectrum Disorder
- Autistic Disorder
- Bacterial Infections
- Breast Neoplasms
- Bronchopulmonary Dysplasia
- Burkitt Lymphoma
- Carcinoma
- Carcinoma in Situ
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Squamous Cell
- Carcinoma, Verrucous
- Central Serous Chorioretinopathy
- Chikungunya Fever
- Child Development Disorders, Pervasive
- Cocaine-Related Disorders
- Communicable Diseases
- Coronavirus Infections
- Critical Illness
- Cryptosporidiosis
- Depression
- Depressive Disorder
- Diabetes Mellitus, Type 1
- Disease
- Edema
- Emergencies
- Encephalitis
- Encephalomyelitis, Eastern Equine
- Encephalomyelitis, Equine
- Encephalomyelitis, Venezuelan Equine
- Encephalomyelitis, Western Equine
- Enterocolitis
- Enterocolitis, Necrotizing
- Epstein-Barr Virus Infections
- Esophageal Neoplasms
- Fibrosis
- Flaviviridae Infections
- Flavivirus Infections
- Frailty
- Gastroesophageal Reflux
- Geographic Atrophy
- Graft vs Host Disease
- Heart Failure
- Hemangioma
- Hemangioma, Capillary
- Hemorrhagic Fever, Ebola
- Hemorrhagic Fevers, Viral
- HIV Infections
- Hodgkin Disease
- Hypertension
- Hypertension, Pulmonary
- Idiopathic Pulmonary Fibrosis
- Immunologic Deficiency Syndromes
- Infarction
- Infections
- Influenza, Human
- Intraabdominal Infections
- Iridocyclitis
- Iritis
- Ischemia
- Ischemic Attack, Transient
- Laryngeal Diseases
- Laryngeal Neoplasms
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Lung Neoplasms
- Lymphoma
- Lymphoma, AIDS-Related
- Lymphoma, B-Cell
- Lymphoma, Large B-Cell, Diffuse
- Lymphoma, Large-Cell, Immunoblastic
- Lymphoma, Non-Hodgkin
- Macular Edema
- Major Depressive Disorder
- Migraine Disorders
- Myocardial Infarction
- Nasopharyngeal Carcinoma
- Neonatal Abstinence Syndrome
- Neoplasms
- Opioid-Related Disorders
- Oropharyngeal Neoplasms
- Papilloma
- Papillomavirus Infections
- Paranasal Sinus Neoplasms
- Parasomnias
- Penile Neoplasms
- Persistent Fetal Circulation Syndrome
- Plasmablastic Lymphoma
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (50)
- NCT06494904CollaboratorPhase 3Nov 30, 2024
- NCT06323824CollaboratorPhase 4Jun 4, 2024
- NCT06023459CollaboratorPhase 3Jan 1, 2024
- NCT06042257CollaboratorPhase 2Dec 31, 2023
- NCT05938465CollaboratorPhase 1/Phase 2Oct 11, 2023
- NCT05382091CollaboratorPhase 2Mar 1, 2023
- NCT04973345CollaboratorPhase 2/Phase 3Mar 31, 2022
- NCT04826094CollaboratorPhase 1Mar 16, 2021
- NCT04729972CollaboratorPhase 2Mar 1, 2021
- NCT04529538CollaboratorPhase 1Jan 31, 2021
- NCT04508309CollaboratorPhase 3Dec 31, 2020
- NCT04464980CollaboratorPhase 4Oct 31, 2020
- NCT04464980CollaboratorPhase 4Oct 31, 2020
- NCT03911739CollaboratorPhase 3Oct 31, 2020
- NCT04345718CollaboratorPhase 2/Phase 3Aug 31, 2020
Details
- Founded
- Rockville, MD, US Jan 1, 1977
- Last known activity
- Nov 30, 2024